EndeavorRx
EndeavorRx is a video game used to treat Attention Deficit Hyperactivity Disorder developed by Akili Interactive. It was based on a prototype game called NeuroRacer. NeuroRacer was developed by Akili Interactive and researchers at the University of San Francisco.[1] The game runs on an engine known as the Akili Selective Stimulus Management engine.[2] EndeavorRx was known as AKL-T01 or Project: EVO ADHD Treatment during its development.[3] On June 15, 2020, it became the first ever video game to be approved by the FDA. It was approved to be used as a treatment for children with ADHD with the age range of 8–12.[4][5][6] Five studies on over 600 children were conducted to measure the effectiveness of EndeavorRx.[7] They found "a 36% improvement in at least one objective measure of attention." The side effects found by the researchers include frustration,[8] dizziness, headaches, and aggression.[9]
In the game, the player is tasked with flying a spaceship across many levels. The player is faced with numerous tasks such as finding collectibles or catching animals. The game will alter its objectives based on the players performance. It may add new rewards and objectives or modify the game's pace in accordance with the pace of the player. EndeavorRx attempts to challenge the player and force them to learn to multitask and ignore distractions.[10] Although EndeavorRx can be downloaded for mobile devices, it cannot be played without a prescription from a physician. It is recommended that the game is played for 25 minutes a day, 5 days a week, for 4 weeks.[11] Once the game has been played for the allotted time it will not let the player continue.[12]
References
[edit]- ^ "Training the Older Brain in 3-D: Video Game Enhances Cognitive Control | UC San Francisco". www.ucsf.edu. 2013-09-04. Archived from the original on March 15, 2023. Retrieved 2023-05-22.
- ^ Canady, Valerie A. (2020-06-29). "FDA approves first video game Rx treatment for children with ADHD". Mental Health Weekly. 30 (26): 1–7. doi:10.1002/mhw.32423. ISSN 1058-1103. S2CID 234731507.
- ^ "Akili preparing FDA bid following strong results of adolescent ADHD trial". MobiHealthNews. 2017-12-04. Archived from the original on December 6, 2022. Retrieved 2023-05-25.
- ^ "Akili Announces FDA Clearance of EndeavorRxTM for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game". www.businesswire.com. 2020-06-15. Archived from the original on August 5, 2022. Retrieved 2023-05-22.
- ^ Park, Andrea (May 3, 2023). "Akili's therapeutic video game improves ADHD symptoms in 83% of adults: study". Archived from the original on May 6, 2023.
- ^ "EndeavorRx, Akili's video game therapeutic, receives FDA De Novo clearance". MobiHealthNews. 2020-06-15. Archived from the original on May 19, 2023. Retrieved 2023-05-25.
- ^ Commissioner, Office of the (2020-06-17). "FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD". FDA. Archived from the original on May 14, 2023. Retrieved 2023-05-25.
- ^ "Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili's EndeavorRx® Video Game-Based Therapeutic". www.businesswire.com. 2023-05-03. Archived from the original on May 13, 2023. Retrieved 2023-05-24.
- ^ Urciuoli, Wendy (2020-07-01). "Wellness Through Answers News v.35:no.3 July-August 2020". Articles - Patient Care.
- ^ "ADHD Treatment For Kids | Digital Therapeutic Video Game for ADHD". EndeavorRx. Retrieved 2023-05-27.
- ^ "An FDA-Approved 'Prescription' Video Game?". The San Francisco Standard. 2023-04-06. Archived from the original on April 14, 2023. Retrieved 2023-05-22.
- ^ Jr, Tom Huddleston (2020-06-17). "See the first-ever video game approved by the FDA as a mental health treatment". CNBC. Archived from the original on November 15, 2022. Retrieved 2023-05-22.